Induction of antitumor cytotoxic T lymphocytes with a MAGE-3-encoded synthetic peptide presented by human leukocytes antigen-A24

Cancer Research

Volumn 57, Issue 20, 1997, Pages 4465-4468

  Tanaka, Fumiaki ^a   Fujie, Tatsuo ^a   Tahara, Kouichirou ^a   Mori, Masaki ^a   Takesako, Kazutoh ^b   Sette, Alessandro ^c   Celis, Esteban ^c   Akiyoshi, Tsuyoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b TAKARA SHUZO CO LTD   (Japan)

^c CYTEL CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; TUMOR ANTIGEN;

ALLELE; ARTICLE; BINDING AFFINITY; CANCER; CANCER IMMUNOTHERAPY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; LYMPHOBLASTOMA; PRIORITY JOURNAL;

ALLELES; AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; B-LYMPHOCYTES; BINDING SITES; CELL LINE; COLONIC NEOPLASMS; CYTOTOXICITY, IMMUNOLOGIC; ESOPHAGEAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HLA-A ANTIGENS; HUMANS; IMMUNOTHERAPY; JAPAN; LEUKEMIA; NEOPLASM PROTEINS; OLIGOPEPTIDES; POLYMERASE CHAIN REACTION; REFERENCE VALUES; STOMACH NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0030871041     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plean, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Washington DC), 254: 1643-1647, 1991.
2. Marchand, M., Weynants, P., Rankin, E., Arienti, F., Belli, F., Parmiani, G., Cascinelli, N., Bourlond, A., Vanwijk, R., Humblet, Y., Canon, J-L., Laurent, C., Naeyaert, J-M., Plagne, R., Deraemaeker, R., Knuth, A., Jager, E., Brasseur, F., Herman, J., Coulie, P. G., and Boon, T. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer, 63: 883-885, 1995.
3. Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plean, E., Amar, C. A., and Boon, T. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytotoxic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med., 176: 1453-1457, 1992.
4. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plean, E., Lethe, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytotoxic T lymphocytes. J. Exp. Med., 179: 921-930, 1994.
5. van der Bruggen, P., Szikora, J-P., Boel, P., Wildmann, C. Somville, M., Sensi, M., and Boon, T. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanoma expressing HLA-Cw1601. Eur. J. Immunol., 24: 2134-2140, 1994.
6. van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P. G., Boël, P., De Smet, C., Traversari, C., Townsend, A., and Boon, T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol., 24: 3038-3043, 1994.
7. Herman, J., van der Bruggen, P., Lueschert, I. F., Mandruzzato, S., Romero, P., Thonnard, J., Fleischhauer, K., Boon, T., and Coulie, P. G. A peptide encoded by human gene MAGE-3 and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Immunogenetics, 43: 377-383, 1996.
8. Celis, E., Fikes, J., Wentworth, P., Sidney, J., Southwood, S., Maewal, A., Del Guercio, M-F., Sette, A., and Livingston, B. Identification of potential CTL epitopes of tumor associated antigen MAGE-1 for five common HLA-A alleles. Mol. Immunol., 31: 1423-1430, 1994.
9. Kubo, R. T., Sette, A., Grey, H. M., Appela, E., Sakaguchi, K., Zhu, N-Z., Arnott, D., Sherman, N., Shabonowitz, J., Michael, H., Bodnar, W. N., Davis, T. A., and Hunt, D. F. Definition of specific peptide motif for four HLA-A alleles. J. Immunol., 152: 3913-3924, 1994.
10. Celis, E., Tsai, V., Crimi, C., DeMars, R., Wentworth, P. A., Chesnut, R. W., Grey, H. M., Sette, A., and Serra, H. M. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA, 91: 2105-2109, 1994.
11. Van Pel, A., van der Bruggen, P., Coulie, P. G., Bricard, V. G., Lethe, B., Van den Eynde, B., Uyttenhove, C., Renauld, J. C., and Boon, T. Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol. Rev., 145: 229-250, 1995.
12. Brasseur, F., Rimoldi, D., Lienard, D., Lethe, B., Carrel, S., Arienti, F., Suter, L., Vanwijck, R., Bourlond, A., Humblet, Y., Vacca, A., Conese, M., Lahaya, T., de Giovanni, G., Deraemaecker, R., Beauduin, M., Sastre, X., Salamon, E., Dreno, B., Jager, E., Knuth, A., Chevreau, C., Siciu, S., Lachapelle, J-M., Pouillart, P., Parmiani, G., Lejeune, F., Cerottini, J-C., Boon, T., and Marchand, M. Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int. J. Cancer. 63: 375-380, 1995.
13. Inoue, H., Mori, M., Li, J., Mimori, K., Honda, M., Nakashima, H., Mafune, K., Tanaka, Y., and Akiyoshi, T. Human esophageal carcinomas frequently express the tumor-rejection antigens of MAGE genes. Int. J. Cancer, 63: 523-526, 1995.
14. Li, J., Yang, Y., Fujie, T., Baba, K., Ueo, H., Mori, M., and Akiyoshi, T. Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma. Clin. Cancer Res., 2: 1619-1625, 1996.
15. Dong, R. P., Kimura, A., Okubo, R., Shinagawa, H., Tamai, H., Nishimura, Y., and Sasazuki, T. HLA-A and DPB1 loci confer susceptibility to Graves' disease. Hum. Immunol., 35: 165-172, 1992.
16. Imanishi, T., Akaza, T., Kimura, A., Tokunaga, K., and Gojobori, T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: K. Tsuji, M. Aizawa, and T. Sasazuki, (ed.), HLA 1991: Proceeding of the Eleventh International Histocompatibility Workshop and Conference, Vol. 1. pp. 1065-1068. Oxford: Oxford University Press, 1992.
17. Tanaka, F., Fujie, T., Go, H., Baba, K., Mori, T., Takesako, K., and Akiyoshi, T. Efficient induction of antitumor cytotoxic T lymphocytes from a healthy donor using HLA-A2-restricted MAGE-3 peptide in vitro. Cancer Immunol. Immunother., 44: 21-26, 1997.
18. Chomczynnski, P. S. N. Single-step method of RNA isolation by acid guanidium thiocyanate-PhOH-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
19. Tokunaga, K., Nakamura, Y., Sakata, K., Fujimori, K., Ohkubo, M., Sawada, K., and Sakiyama, S. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res., 47: 5616-5619, 1987.